Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs ORCHID PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH ORCHID PHARMA PROCTER & GAMBLE HEALTH/
ORCHID PHARMA
 
P/E (TTM) x 34.5 41.8 82.5% View Chart
P/BV x 10.5 7.7 136.6% View Chart
Dividend Yield % 2.0 0.0 -  

Financials

 PROCTER & GAMBLE HEALTH   ORCHID PHARMA
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
ORCHID PHARMA
Mar-23
PROCTER & GAMBLE HEALTH/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs5,366439 1,223.6%   
Low Rs3,883273 1,421.8%   
Sales per share (Unadj.) Rs740.7163.1 454.1%  
Earnings per share (Unadj.) Rs138.213.5 1,021.4%  
Cash flow per share (Unadj.) Rs155.227.0 575.6%  
Dividends per share (Unadj.) Rs95.000-  
Avg Dividend yield %2.10-  
Book value per share (Unadj.) Rs447.6168.7 265.3%  
Shares outstanding (eoy) m16.6040.82 40.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.22.2 286.2%   
Avg P/E ratio x33.526.3 127.3%  
P/CF ratio (eoy) x29.813.2 225.8%  
Price / Book Value ratio x10.32.1 489.9%  
Dividend payout %68.70-   
Avg Mkt Cap Rs m76,76114,522 528.6%   
No. of employees `000NANA-   
Total wages/salary Rs m2,062654 315.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,2966,659 184.7%  
Other income Rs m184194 94.6%   
Total revenues Rs m12,4806,853 182.1%   
Gross profit Rs m3,2471,235 262.9%  
Depreciation Rs m281548 51.3%   
Interest Rs m8329 2.3%   
Profit before tax Rs m3,142552 568.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8470-   
Profit after tax Rs m2,295552 415.4%  
Gross profit margin %26.418.5 142.4%  
Effective tax rate %27.00-   
Net profit margin %18.78.3 224.9%  
BALANCE SHEET DATA
Current assets Rs m11,7135,010 233.8%   
Current liabilities Rs m6,7913,719 182.6%   
Net working cap to sales %40.019.4 206.4%  
Current ratio x1.71.3 128.0%  
Inventory Days Days26357 458.1%  
Debtors Days Days3431,180 29.1%  
Net fixed assets Rs m10,6177,242 146.6%   
Share capital Rs m166408 40.7%   
"Free" reserves Rs m7,2656,478 112.1%   
Net worth Rs m7,4316,886 107.9%   
Long term debt Rs m01,488 0.0%   
Total assets Rs m22,33012,252 182.3%  
Interest coverage x409.12.7 15,268.0%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.60.5 101.3%   
Return on assets %10.37.2 143.3%  
Return on equity %30.98.0 384.9%  
Return on capital %42.410.5 402.7%  
Exports to sales %081.9 0.0%   
Imports to sales %13.137.6 34.8%   
Exports (fob) Rs mNA5,452 0.0%   
Imports (cif) Rs m1,6052,501 64.2%   
Fx inflow Rs m1,4655,452 26.9%   
Fx outflow Rs m1,6052,726 58.9%   
Net fx Rs m-1402,726 -5.1%   
CASH FLOW
From Operations Rs m2,360183 1,286.9%  
From Investments Rs m-215-312 68.9%  
From Financial Activity Rs m-985312 -316.0%  
Net Cashflow Rs m1,160183 634.4%  

Share Holding

Indian Promoters % 0.0 69.8 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 20.3 18.6 108.7%  
FIIs % 7.6 4.1 183.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 30.2 159.7%  
Shareholders   56,730 36,931 153.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Procter & Gamble Health vs Orchid Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs Orchid Pharma Share Price Performance

Period Procter & Gamble Health Orchid Pharma S&P BSE HEALTHCARE
1-Day -0.55% -0.40% 1.18%
1-Month -7.47% -14.06% -0.75%
1-Year -3.02% 173.54% 61.82%
3-Year CAGR -9.12% -23.64% 18.16%
5-Year CAGR 5.75% 184.58% 19.79%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the Orchid Pharma share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Orchid Pharma the stake stands at 69.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Orchid Pharma.

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.

Orchid Pharma paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Orchid Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.